Impact of Routine Use of Drug-eluting Stents in Contemporary Interventional Cardiology at a Tertiary Center: One-decade Experience of the DESIRE Registry

نویسندگان

  • J. Ribamar Costa Junior
  • Amanda G. M. R. Sousa
  • Adriana Costa Moreira
  • Ricardo A. da Costa
  • Galo Maldonado
  • Manuel N. Cano
  • Cantídio Campos Neto
  • J. Eduardo Sousa
چکیده

background: Drug-eluting stents (DES) have changed contemporary interventional cardiology practice, enabling the approach of increasingly more complex clinical and angiographic scenarios. The objective of this study was to demonstrate the changes observed in the last 10 years in the indication and practice of percutaneous coronary intervention (PCI) at a tertiary private hospital in the State of São Paulo. Methods: DESIRE is a single-center prospective registry aiming at following the acute and late outcomes of consecutive patients treated by DES. Results: From 2002 to 2011, 4,299 patients were included, with mean age of 64.3 ± 11.2 years, 23% were female and 30.5 were diabetic. The total number of lesions treated was 6,518 of which 61.5% were type B2/C. During the course of the study, DES were progressively more used, reaching a penetration of 88.4% in 2011. The complexity of PCIs has increased and in the past year 1.76 lesions per patient were treated with an average of 1.89 DES. The SYNTAX score increased from 12.3 ± 4.4 (2002-2006) to 15.7 ± 4.7 (2007-2011). Clinical follow-up was obtained in 98.2% of the patients, with a median of 5.2 years, and during this period target-lesion revascularization rate was 5%, myocardial infarction was 6.7% and cardiovascular death was 4.1%. Stent thrombosis was observed in 2.4% of the cases. Conclusions: Our results showed a marked increment in the complexity profile of patients treated in the last 10 years and at the same time confirm the long-term 1 Doctor. Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 2 Full Professor. Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brasil. São Paulo, SP, Brazil. 3 Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 4 Doctor. Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 5 Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 6 Cardiologist Physician at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 7 Engineer and programmer at Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. 8 Full professor. Head of Invasive Cardiology Service of do Hospital do Coração da Associação do Sanatório Sírio. São Paulo, SP, Brazil. Correspondence to: J. Eduardo Sousa. Rua Abílio Soares, 250 – 12o andar – Paraíso – São Paulo, SP, Brazil – CEP 04005-000 E-mail: [email protected] Received on: 10/8/2012 • Accepted on: 12/4/2012 Original Article

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bringing reality to drug-eluting stents.

TThe introduction of drug-eluting stents has unquestionably been one of the most important advances in interventional cardiology during the past decade. The impact has already been profound, despite the release of the first drug-eluting stent, the Cypher stent (Cordis Corp), in the United States earlier this year. Practitioners are now using these devices for a wide variety of clinical and anat...

متن کامل

Editorial - Ajay J. Kirtane - ingles.pmd

1 Columbia University Medical Center/New York-Presbyterian Hospital – New York, NY, USA. Correspondence: Ajay J. Kirtane. Division of Cardiology, Columbia University Medical Center/New York-Presbyterian Hospital – 161 Fort Washington Avenue – 5th Floor – New York, NY, USA – 10032 E-mail: [email protected] Received on: 9/18/2011 • Accepted on: 9/18/2011 T he advent of drug-eluting stents (DE...

متن کامل

Optimal Stent Expansion by Stent Balloon Multiple Inflation at Nominal Pressure in Resistant Lesions: A New Technique

Introduction: This study aimed to evaluate the effects of four-time inflation of the stent balloon at nominal pressure on optimal stent expansion in resistant lesions. Materials and Methods: This interventional study was conducted on 39 patients with coronary artery lesions, in whom Zotarolimus-eluting stents (N=20), Paclitaxel-eluting stents (N=11) and other stents (N=8) were deployed four tim...

متن کامل

[Insulin-dependent. Rapamycin-resistant?].

The development of drug-eluting stents has revolutionized interventional cardiology. In Spain, 25 148 drug-eluting stents were implanted in 2004, according to the Registro Español de Hemodinámica y Cardiología Intervencionista (Spanish Registry of Hemodynamics and Interventional Cardiology).1 Based on the results of key randomized studies with sirolimuseluting2,3 and paclitaxel-eluting stents,4...

متن کامل

Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis.

AIMS We performed a propensity score matched analysis to explore whether TiNOX stents are superior to paclitaxel- (PES) and sirolimus-eluting stents (SES) in routine clinical practice. METHODS AND RESULTS A total of 1,607 patients undergoing implantation of SES, PES or TiNOX stents were prospectively entered into a stent registry and followed up for three years. Using propensity score matchin...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014